ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014–2019

Aim: Secondary bloodstream infections (SBSIs) are caused by another infection and differ from primary bloodstream infections (PBSIs) in terms of prevention and treatment strategies. The aim of this study was to determine the risk factors for bloodstream infections which were secondary to the most co...

Full description

Bibliographic Details
Main Authors: Hekimoglu, Can Huseyin, Yildiz, Serap Suzuk, Sahan, Selda, Batir, Esen, Yildirim Gozel, Emine, Altun, Dilek, Pehlivanturk, Gulen, Comce, Muhammet, Kara, Fatih
Format: Article
Language:deu
Published: German Medical Science GMS Publishing House 2022-04-01
Series:GMS Hygiene and Infection Control
Subjects:
Online Access:http://www.egms.de/static/en/journals/dgkh/2022-17/dgkh000408.shtml
_version_ 1818670370952052736
author Hekimoglu, Can Huseyin
Yildiz, Serap Suzuk
Sahan, Selda
Batir, Esen
Yildirim Gozel, Emine
Altun, Dilek
Pehlivanturk, Gulen
Comce, Muhammet
Kara, Fatih
author_facet Hekimoglu, Can Huseyin
Yildiz, Serap Suzuk
Sahan, Selda
Batir, Esen
Yildirim Gozel, Emine
Altun, Dilek
Pehlivanturk, Gulen
Comce, Muhammet
Kara, Fatih
author_sort Hekimoglu, Can Huseyin
collection DOAJ
description Aim: Secondary bloodstream infections (SBSIs) are caused by another infection and differ from primary bloodstream infections (PBSIs) in terms of prevention and treatment strategies. The aim of this study was to determine the risk factors for bloodstream infections which were secondary to the most common healthcare-associated infections caused by the most common microorganisms in intensive care units (ICUs) and to examine whether extended-spectrum beta lactamase (ESBL) production and carbapenem resistance is related to the higher risk or not.Methods: The study population consisted of patients in ICUs with ventilator-associated pneumonia (VAP), ventilator-associated event (VAE) or catheter-associated urinary tract infection (CAUTI) caused by or between 2014 and 2019. The data were obtained through the National Healthcare-associated Infections Surveillance Network. Multivariate logistic regression analysis was performed separately for VAP/VAE and CAUTI to determine the risk factors for the development of SBSI.Results: Microorganism, ICU type, bed capasity and carbapenem resistance were found to be risk factors for SBSI for both types of infection. For VAPs/VAEs, female gender and hospital type were also identified as risk factors. The highest risk was in and in emergency ICUs. Among the hospitals, the highest risk in VAPs/VAEs was found in government education and research hospitals. ESBL production for . and increased the risk in patients with VAP/VAE; however, it did not increase in patients with CAUTI.Discussion: By using the risk factors, it may be possible to recognize SBSIs earlier, especially in patients with CAUTIs or VAPs/VAEs caused by carbapenem-resistant or ESBL-producing .
first_indexed 2024-12-17T07:07:02Z
format Article
id doaj.art-97cd6f3d1a0e406eba66259e11930a67
institution Directory Open Access Journal
issn 2196-5226
language deu
last_indexed 2024-12-17T07:07:02Z
publishDate 2022-04-01
publisher German Medical Science GMS Publishing House
record_format Article
series GMS Hygiene and Infection Control
spelling doaj.art-97cd6f3d1a0e406eba66259e11930a672022-12-21T21:59:08ZdeuGerman Medical Science GMS Publishing HouseGMS Hygiene and Infection Control2196-52262022-04-0117Doc0510.3205/dgkh000408ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014–2019Hekimoglu, Can Huseyin0Yildiz, Serap Suzuk1Sahan, Selda2Batir, Esen3Yildirim Gozel, Emine4Altun, Dilek5Pehlivanturk, Gulen6Comce, Muhammet7Kara, Fatih8Ministry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, TurkeyMinistry of Health, General Directorate of Public Health, Department of Microbiology Reference Laboratory and Biological Products, Ankara, TurkeyMinistry of Health, General Directorate of Public Health, Department of Tuberculosis, Ankara, TurkeyMinistry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, TurkeyMinistry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, TurkeyMinistry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, TurkeyMinistry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, TurkeyMinistry of Health, General Directorate of Public Health, Ankara, TurkeyMinistry of Health, General Directorate of Public Health, Ankara, TurkeyAim: Secondary bloodstream infections (SBSIs) are caused by another infection and differ from primary bloodstream infections (PBSIs) in terms of prevention and treatment strategies. The aim of this study was to determine the risk factors for bloodstream infections which were secondary to the most common healthcare-associated infections caused by the most common microorganisms in intensive care units (ICUs) and to examine whether extended-spectrum beta lactamase (ESBL) production and carbapenem resistance is related to the higher risk or not.Methods: The study population consisted of patients in ICUs with ventilator-associated pneumonia (VAP), ventilator-associated event (VAE) or catheter-associated urinary tract infection (CAUTI) caused by or between 2014 and 2019. The data were obtained through the National Healthcare-associated Infections Surveillance Network. Multivariate logistic regression analysis was performed separately for VAP/VAE and CAUTI to determine the risk factors for the development of SBSI.Results: Microorganism, ICU type, bed capasity and carbapenem resistance were found to be risk factors for SBSI for both types of infection. For VAPs/VAEs, female gender and hospital type were also identified as risk factors. The highest risk was in and in emergency ICUs. Among the hospitals, the highest risk in VAPs/VAEs was found in government education and research hospitals. ESBL production for . and increased the risk in patients with VAP/VAE; however, it did not increase in patients with CAUTI.Discussion: By using the risk factors, it may be possible to recognize SBSIs earlier, especially in patients with CAUTIs or VAPs/VAEs caused by carbapenem-resistant or ESBL-producing .http://www.egms.de/static/en/journals/dgkh/2022-17/dgkh000408.shtmlsecondary bloodstream infectioncatheter-associated urinary tract infectionventilator-associated pneumoniaventilator-associated eventcarbapenem resistanceextended spectrum beta-lactamase
spellingShingle Hekimoglu, Can Huseyin
Yildiz, Serap Suzuk
Sahan, Selda
Batir, Esen
Yildirim Gozel, Emine
Altun, Dilek
Pehlivanturk, Gulen
Comce, Muhammet
Kara, Fatih
ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014–2019
GMS Hygiene and Infection Control
secondary bloodstream infection
catheter-associated urinary tract infection
ventilator-associated pneumonia
ventilator-associated event
carbapenem resistance
extended spectrum beta-lactamase
title ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014–2019
title_full ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014–2019
title_fullStr ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014–2019
title_full_unstemmed ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014–2019
title_short ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014–2019
title_sort esbl production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in turkey 2014 2019
topic secondary bloodstream infection
catheter-associated urinary tract infection
ventilator-associated pneumonia
ventilator-associated event
carbapenem resistance
extended spectrum beta-lactamase
url http://www.egms.de/static/en/journals/dgkh/2022-17/dgkh000408.shtml
work_keys_str_mv AT hekimoglucanhuseyin esblproductionandcarbapenemresistanceincreasedthesecondarybloodstreaminfectionratesinintensivecareunitsinturkey20142019
AT yildizserapsuzuk esblproductionandcarbapenemresistanceincreasedthesecondarybloodstreaminfectionratesinintensivecareunitsinturkey20142019
AT sahanselda esblproductionandcarbapenemresistanceincreasedthesecondarybloodstreaminfectionratesinintensivecareunitsinturkey20142019
AT batiresen esblproductionandcarbapenemresistanceincreasedthesecondarybloodstreaminfectionratesinintensivecareunitsinturkey20142019
AT yildirimgozelemine esblproductionandcarbapenemresistanceincreasedthesecondarybloodstreaminfectionratesinintensivecareunitsinturkey20142019
AT altundilek esblproductionandcarbapenemresistanceincreasedthesecondarybloodstreaminfectionratesinintensivecareunitsinturkey20142019
AT pehlivanturkgulen esblproductionandcarbapenemresistanceincreasedthesecondarybloodstreaminfectionratesinintensivecareunitsinturkey20142019
AT comcemuhammet esblproductionandcarbapenemresistanceincreasedthesecondarybloodstreaminfectionratesinintensivecareunitsinturkey20142019
AT karafatih esblproductionandcarbapenemresistanceincreasedthesecondarybloodstreaminfectionratesinintensivecareunitsinturkey20142019